Filing Details
- Accession Number:
- 0000950170-24-100281
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-23 18:13:05
- Reporting Period:
- 2024-08-22
- Accepted Time:
- 2024-08-23 18:13:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1719714 | Mereo Biopharma Group Plc | MREO | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1270734 | Deepika Pakianathan | C/O Mereo Biopharma Group Plc 4Th Floor, One Cavendish Place London X0 W1G 0QF | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| American Depositary Shares Representing Ordinary Shares | Acquisiton | 2024-08-22 | 1,825 | $3.00 | 1,825 | No | 4 | M | Direct | |
| American Depositary Shares Representing Ordinary Shares | Acquisiton | 2024-08-22 | 6,492 | $1.84 | 8,317 | No | 4 | M | Direct | |
| American Depositary Shares Representing Ordinary Shares | Acquisiton | 2024-08-22 | 12,418 | $2.72 | 20,735 | No | 4 | M | Direct | |
| American Depositary Shares Representing Ordinary Shares | Acquisiton | 2024-08-22 | 38,953 | $1.31 | 59,688 | No | 4 | M | Direct | |
| American Depositary Shares Representing Ordinary Shares | Acquisiton | 2024-08-22 | 43,485 | $0.94 | 103,173 | No | 4 | M | Direct | |
| American Depositary Shares Representing Ordinary Shares | Acquisiton | 2024-08-22 | 2,071 | $3.87 | 105,244 | No | 4 | M | Direct | |
| American Depositary Shares Representing Ordinary Shares | Disposition | 2024-08-22 | 105,244 | $4.43 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| American Depository Shares | Share Options (right to buy) | Disposition | 2024-08-22 | 5,500 | $0.00 | 5,500 | $3.00 |
| American Depository Shares | Share Options (right to buy) | Disposition | 2024-08-22 | 11,000 | $0.00 | 11,000 | $1.84 |
| American Depository Shares | Share Options (right to buy) | Disposition | 2024-08-22 | 31,500 | $0.00 | 31,500 | $2.72 |
| American Depository Shares | Share Options (right to buy) | Disposition | 2024-08-22 | 55,000 | $0.00 | 55,000 | $1.31 |
| American Depository Shares | Share Options (right to buy) | Disposition | 2024-08-22 | 55,000 | $0.00 | 55,000 | $0.94 |
| American Depository Shares | Share Options (right to buy) | Disposition | 2024-08-22 | 15,000 | $0.00 | 15,000 | $3.87 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2029-07-23 | No | 4 | M | Direct | |
| 0 | 2030-02-20 | No | 4 | M | Direct | |
| 0 | 2031-02-01 | No | 4 | M | Direct | |
| 0 | 2032-02-01 | No | 4 | M | Direct | |
| 0 | 2033-02-01 | No | 4 | M | Direct | |
| 30,000 | 2034-02-08 | No | 4 | M | Direct |
Footnotes
- Each American Depositary Share ("ADS") represents five ordinary shares of the Issuer.
- Sale is due to fund administration reasons.
- The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $4.360 to $4.495, inclusive. The Reporting Person undertakes to provide to Mereo BioPharma Group plc ("Mereo"), any security holder of Mereo, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ADSs sold at each separate price within the ranges set forth in footnote (3) to this Form
- Vested in substantially equal monthly installments over a one year period from the July 23, 2019 grant date.
- Vested in substantially equal monthly installments over a one year period from the February 20, 2020 grant date.
- Vested in substantially equal monthly installments over a one year period from the February 1, 2021 grant date.
- Vested in substantially equal monthly installments over a one year period from the February 1, 2022 grant date.
- Vested in substantially equal monthly installments over a one year period from the February 1, 2023 grant date.
- Vests in substantially equal monthly installments over a one year period from the February 8, 2024 grant date. As of June 8, 2024, 15,000 Share Options have vested.
Billionaire Hedge Funds
